Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials

Neurology
Scott Y H KimBenjamin E Berkman

Abstract

Prevention trials for neurodegenerative diseases use genetic or other risk marker tests to select participants but there is concern that this could involve coercive disclosure of unwanted information. This has led some trials to use blinded enrollment (participants are tested but not told of their risk marker status). We examined the ethics of blinded vs transparent enrollment using well-established criteria for assessing the ethics of clinical research. Normative analysis applying 4 key ethical criteria-favorable risk-benefit ratio, informed consent, fair subject selection, and scientific validity-to blinded vs transparent enrollment, using current evidence and state of Alzheimer disease (AD) and other prevention trials. Current evidence on the psychosocial impact of risk marker disclosure and considerations of scientific benefit do not support an obligation to use blinded enrollment in prevention trials. Nor does transparent enrollment coerce or involve undue influence of potential participants. Transparent enrollment does not unfairly exploit vulnerable participants or limit generalizability of scientific findings of prevention trials. However, if the preferences of a community of potential participants would affect the rigo...Continue Reading

Citations

Mar 19, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·José L MolinuevoJason Karlawish
Jul 24, 2015·Alzheimer's Research & Therapy·Joshua D GrillUNKNOWN Dominantly Inherited Alzheimer’s Network
Apr 17, 2018·Sociology of Health & Illness·Richard MilneKatie Wells
Oct 28, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Piotr LewczukUNKNOWN Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato
Aug 30, 2018·Journal of Medical Ethics·Eline M BunnikMaartje H N Schermer
Feb 27, 2018·Journal of Alzheimer's Disease : JAD·Richard MilneCarol Brayne
Jan 11, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Carolyn M LangloisJessica B Langbaum
Aug 11, 2018·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Jennifer H LinglerOscar L Lopez
Dec 8, 2017·Alzheimer's Research & Therapy·Joshua D Grill, Jason Karlawish
Jan 20, 2017·Geriatrics·James Alvin Low, Esther Ho
Dec 14, 2018·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Amaranta Manrique de LaraMiguel E Rentería
Dec 6, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Cristina SampaioRobert Klitzman
Mar 6, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Claire M EricksonLindsay R Clark
Apr 17, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Daniel A WilkenfeldJennifer H Lingler
Jul 13, 2021·Journal of the American Geriatrics Society·Emily A LargentUNKNOWN REVEAL-SCAN Team

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice
Carol L Freund, Benjamin S Wilfond
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Jason KarlawishDaniel Marson
© 2021 Meta ULC. All rights reserved